These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2026502)

  • 1. Positron labeled muscarinic acetylcholine receptor antagonist: 2- and 4-[18F]fluorodexetimide. Syntheses and biodistribution.
    Hwang DR; Dence CS; McKinnon ZA; Mathias CJ; Welch MJ
    Int J Rad Appl Instrum B; 1991; 18(2):247-52. PubMed ID: 2026502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo biodistribution of two [18F]-labelled muscarinic cholinergic receptor ligands: 2-[18F]- and 4-[18F]-fluorodexetimide.
    Wilson AA; Scheffel UA; Dannals RF; Stathis M; Ravert HT; Wagner HN
    Life Sci; 1991; 48(14):1385-94. PubMed ID: 2008155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET Imaging of brain muscarinic receptors with
    Rowe CC; Krishnadas N; Ackermann U; Doré V; Goh RYW; Guzman R; Chong L; Bozinovski S; Mulligan R; Kanaan R; Dean B; Villemagne VL
    Psychiatry Res Neuroimaging; 2021 Oct; 316():111354. PubMed ID: 34399286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization and positron emission tomography evaluation of 4-[76Br]bromodexetimide and 4-[76Br]bromolevetimide for investigations of central muscarinic cholinergic receptors.
    Loc'h C; Kassiou M; Strijckmans V; Bottlaender M; Katsifis A; Schmid L; Mazière M; Lambrecht RM; Mazière B
    Nucl Med Biol; 1996 Apr; 23(3):235-43. PubMed ID: 8782231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo visualization of central muscarinic receptors using [11C]quinuclidinyl benzilate and positron emission tomography in baboons.
    Varastet M; Brouillet E; Chavoix C; Prenant C; Crouzel C; Stulzaft O; Bottlaender M; Cayla J; Mazière B; Mazière M
    Eur J Pharmacol; 1992 Mar; 213(2):275-84. PubMed ID: 1521561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo imaging of muscarinic cholinergic receptors in temporal lobe epilepsy with a new PET tracer: [76Br]4-bromodexetimide.
    Dupont S; Semah F; Loc'h C; Strijckmans V; Baulac M; Samson Y; Mazière B
    J Nucl Med; 1999 Jun; 40(6):935-41. PubMed ID: 10452308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 123I-iododexetimide preferentially binds to the muscarinic receptor subtype M1 in vivo.
    Bakker G; Vingerhoets WA; van Wieringen JP; de Bruin K; Eersels J; de Jong J; Chahid Y; Rutten BP; DuBois S; Watson M; Mogg AJ; Xiao H; Crabtree M; Collier DA; Felder CC; Barth VN; Broad LM; Bloemen OJ; van Amelsvoort TA; Booij J
    J Nucl Med; 2015 Feb; 56(2):317-22. PubMed ID: 25593117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of [125I]- and [123I]-4-iododexetimide, a potent muscarinic cholinergic receptor antagonist.
    Wilson AA; Dannals RF; Ravert HT; Frost JJ; Wagner HN
    J Med Chem; 1989 May; 32(5):1057-62. PubMed ID: 2785211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholinesterase inhibition increases in vivo N-(2-[18F]fluoroethyl)-4-piperidyl benzilate binding to muscarinic acetylcholine receptors.
    Skaddan MB; Kilbourn MR; Snyder SE; Sherman PS
    J Cereb Blood Flow Metab; 2001 Feb; 21(2):144-8. PubMed ID: 11176279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomographic investigations of central muscarinic cholinergic receptors with three isomers of [76Br]BrQNP.
    Strijckmans V; Bottlaender M; Luo H; Ottaviani M; McPherson DW; Loc'h C; Fuseau C; Knapp FF; Mazière B
    Eur J Nucl Med; 1997 May; 24(5):475-82. PubMed ID: 9142726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using single photon emission tomography (SPECT) and positron emission tomography (PET) to trace the distribution of muscarinic acetylcholine receptor (MACHR) binding radioligands.
    Kiesewetter DO; Carson RE; Jagoda EM; Herscovitch P; Eckelman WC
    Life Sci; 1999; 64(6-7):511-8. PubMed ID: 10069517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of extracellular acetylcholine on muscarinic receptor binding assessed by [125I]dexetimide and a simple probe.
    Sánchez-Roa PM; Wagner HN; Villemagne VL; London ED; Lever JR
    Eur J Pharmacol; 1998 Oct; 358(3):207-11. PubMed ID: 9822886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo characterization of 4-[125I]iododexetimide binding to muscarinic cholinergic receptors in the rat heart.
    Matsumura K; Uno Y; Scheffel U; Wilson AA; Dannals RF; Wagner HN
    J Nucl Med; 1991 Jan; 32(1):76-80. PubMed ID: 1988640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of radiotracers for studying muscarinic cholinergic receptors in the living human brain using positron emission tomography: [11C]dexetimide and [11C]levetimide.
    Dannals RF; Långström B; Ravert HT; Wilson AA; Wagner HN
    Int J Rad Appl Instrum A; 1988; 39(4):291-5. PubMed ID: 2838435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses.
    Mulholland GK; Wieland DM; Kilbourn MR; Frey KA; Sherman PS; Carey JE; Kuhl DE
    Synapse; 1998 Nov; 30(3):263-74. PubMed ID: 9776130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosynthesis of [123I]N-methyl-4-iododexetimide and [123I]N-methyl-4-iodolevetimide: in vitro and in vivo characterisation of binding to muscarinic receptors in the rat heart.
    Kassiou M; Mardon K; Katsifis AG; Najdovski L; Dikic B; Mattner F; Lambrecht RM; Hicks RJ; Eu P; Loc'h C
    Nucl Med Biol; 1996 Feb; 23(2):147-53. PubMed ID: 8868287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of acetylcholine on binding of 4-[125I]iododexetimide to muscarinic brain receptors.
    Weckesser M; Fixmann A; Holschbach M; Müller-Gärtner HW
    Nucl Med Biol; 1998 Nov; 25(8):777-80. PubMed ID: 9863566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human dosimetry and biodistribution of iodine-123-iododexetimide: a SPECT imaging agent for cholinergic muscarinic neuroreceptors.
    Boundy KL; Barnden LR; Rowe CC; Reid M; Kassiou M; Katsifis AG; Lambrecht RM
    J Nucl Med; 1995 Jul; 36(7):1332-8. PubMed ID: 7790964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-(3-[18F]fluoropropyl)-N-nordiprenorphine: synthesis and characterization of a new agent for imaging opioid receptors with positron emission tomography.
    Chesis PL; Hwang DR; Welch MJ
    J Med Chem; 1990 May; 33(5):1482-90. PubMed ID: 2158564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2- and 4-[18F]fluorotropapride, two specific D2 receptor ligands for positron emission tomography: N.C.A. syntheses and animal studies.
    Damhaut P; Cantineau R; Lemaire C; Plenevaux A; Christiaens L; Guillaume M
    Int J Rad Appl Instrum A; 1992 Oct; 43(10):1265-74. PubMed ID: 1330979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.